Resources

You are here

Frost & Sullivan Australia White Paper

Executive Summary | Full Report

Frost & Sullivan Asia White Paper

Executive Summary | Full Report (English) 
Full Report (Chinese)

Case studies

 

Feasibility and Disease Report Library

Asia Pacific, a hub for clinical trials in NAFLD

Asia Pacific, a hub for clinical trials in NAFLD

Non-alcoholic fatty liver diseases (NAFLD) are one of the most common liver disorder in developed countries and are particularly prevalent in Asian countries, especially in South Korea and Taiwan. Over a third of all industry-sponsored clinical studies initiated during the period (2015-2017) involved sites located in a country in which Novotech operates.

Click here to learn more and download the report

Liver cancer landscape in Asia

Liver cancer landscape in Asia

Hepatocellular carcinoma (HCC) and bile duct malignancies are highly prevalent in Asia, especially in South Korea and in Japan where the prevalence rate is about 5 times higher than in Western countries. Chronic viral hepatitis infections as well as fatty liver diseases (NASH in particular), which are endemic in this part of the world, are known to markedly increase the risk of developing HCC and explain the high rates observed in Asia.

Click here to learn more and download the report

Hepatitis B landscape in Asia

Hepatitis B landscape in Asia

It is estimated that at least 2 billion people or one third of the world’s population have been infected with HBV. Approximately 240 million people or 6% of the world’s population are chronically infected and the Asia Pacific region represents three quarters of chronic HBV patients worldwide.

Click here to learn more and download the report

Gastric cancer landscape in Asia

Gastric cancer landscape in Asia

Gastric Cancer malignancies are highly prevalent in Asia, especially in South Korea and in Japan where the prevalence rate is about 10 times higher than in Western countries. Diet and lifestyle such as alcohol consumption, smoking and obesity, as well as other factors such as Helicobacter pylori infections, are known to increase the risk of developing Gastric Cancer and explain the high rates of cases observed in Asia.

Click here to learn more and download the report